PROM1 and neoplasm: We applied the KMC14-cell isolation method for other 6 PDAC patients who resisted gemcitabine, and established 6 CD133+ tumor-initiating cells that required stromal cells for their in vitro clonogenic activity (Tables 1 and 3).